Pallavi Ail

(Reuters) - GTx Inc's experimental drug to treat muscle wasting in cancer patients became its second successive lead drug to fail late-stage trials, wiping out nearly two-thirds of the market...

(Reuters) - GTx Inc's experimental drug to treat muscle wasting in cancer patients became its second successive lead drug to fail late-stage trials, wiping out nearly two-thirds of the market...

WASHINGTON (Reuters) - The U.S. Food and Drug Administration said on Monday it is investigating a multi-state outbreak of an intestinal infection called cyclosporiasis, whose cause has not yet been...

(Reuters) - A radical new treatment for genetic disorders has catapulted Alnylam Pharmaceuticals Inc into the crosshairs of investors seeking the next breakthrough name in biotechnology. The challenge for the...

(Reuters) - A radical new treatment for genetic disorders has catapulted Alnylam Pharmaceuticals Inc into the crosshairs of investors seeking the next breakthrough name in biotechnology. The challenge for the...

(Reuters) - WebMD Health Corp said Chief Executive Cavan Redmond will be leaving the health information provider, less than a year after the former Pfizer Inc executive was appointed to...

(Reuters) - WebMD Health Corp said Chief Executive Cavan Redmond will be leaving the health information provider, less than a year after the former Pfizer Inc executive was appointed to...

(Reuters) - Medical device maker HeartWare International Inc reported a smaller-than-expected first-quarter loss after sales of its heart pump soared 62 percent, sending its shares up 8 percent in after-market...

(Reuters) - Medical device maker HeartWare International Inc reported a smaller-than-expected first-quarter loss after sales of its heart pump soared 62 percent, sending its shares up 8 percent in after-market...